January 22, 2018 03:16 PM ESTUpdated January 23, 12:59 PM

FDA slaps down Braeburn on opioid addiction drug, putting Indivior and Alkermes in strong position

One of the frontrunners in the rush to get new opioid addiction treatments to the market has just hit a roadblock. Just days before its …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA slaps down Brae­burn on opi­oid ad­dic­tion drug, putting In­di­v­ior and Alk­er­mes in strong po­si­tion